BioWorld MedTech

Jan. 4, 2010

Technique uses patient's veins to replace infected aortic grafts

A new technique designed to replace infected aortic grafts with the person's own veins is proving to be more durable and less prone to new infection than those procedures which use synthetic and cadaver grafts. (Medical Device Daily) Read More

Deals roundup: Anika buys FAB for $17.1M and nearly 2 million shares

Washington roundup: NICE recommends limited use of ablation for CRC to liver

John's Hopkins to study value of text messaging with patients

Report from Europe: Wright Medical to spend $4M to move French operations

Holiday notice

Today's MDD food for med-tech thought

Med-Tech Notes

Agreements/contracts: Acacia subsidiary licenses PACS technology to Stryker

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 9, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Impact of Trump tariffs on med tech proving difficult to anticipate

BioWorld MedTech

The Trump administration’s declaration of a new round of tariffs did not sit well with trade associations, but the impact of those tariffs may vary somewhat by...